The DOI matches its Crossref record; 88 of the 89 references it cites were found in a registry or an index.
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Abstract
CONTEXT: A long-standing version of the dopamine hypothesis of schizophrenia postulates that hyperactivity of dopaminergic transmission at D(2) receptors in the limbic striatum is associated with the illness and that blockade of mesolimbic D(2) receptors is responsible for the antipsychotic action of D(2) receptor antagonists. OBJECTIVE: To localize dopaminergic hyperactivity within the striatum in schizophrenia. DESIGN: Case-control study. SETTING: Inpatient research unit. PARTICIPANTS: Eighteen untreated patients with schizophrenia and 18 healthy control subjects matched for age, sex, ethnicity, parental socioeconomic status, cigarette smoking, and weight. MAIN OUTCOME MEASURES: Percentage change in dopamine D(2) receptor availability in striatal subregions within each subject measured by positron emission tomography with carbon 11-labeled raclopride before and during pharmacologically induced dopamine depletion. RESULTS: In the associative striatum, acute dopamine depletion resulted in a larger increase in D(2) receptor availability in patients with schizophrenia (mean [SD], 15% [7%]) than in control subjects (10% [7%], P = .045), suggesting higher synaptic dopamine concentration. Within the associative striatum, this effect was most pronounced in the precommissural dorsal caudate (15% [8%] in patients vs 9% [8%] in controls, P = .03). No between-group differences were observed in the limbic and sensorimotor striatum. CONCLUSIONS: These findings suggest that schizophrenia is associated with elevated dopamine function in associative regions of the striatum. Because the precommissural dorsal caudate processes information from the dorsolateral prefrontal cortex, this observation also suggests that elevated subcortical dopamine function might adversely affect performance of the dorsolateral prefrontal cortex in schizophrenia. On the other hand, the absence of a group difference in the limbic striatum brings into question the therapeutic relevance of the mesolimbic selectivity of second-generation antipsychotic drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Synaptic dopamine is also increased in psychosis(50, 51).”
From Aberrant Salience, Information Processing, and Dopaminergic Signaling in People at Clinical High Risk for Psychosis (2020) · cites this paper as [50]
In the citing paper
“In CHR subjects in general, as well as in the subgroup that later become psychotic, the greatest alterations in dopamine synthesis and release capacity have been found in the associative striatum (57-59, 62), paralleling findings in psychotic patients(50, 69).”
From Aberrant Salience, Information Processing, and Dopaminergic Signaling in People at Clinical High Risk for Psychosis (2020) · cites this paper as [50]
In the citing paper
“a PET study found higher synaptic DA concentrations in the ventral striatum in schizophrenia [425].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [425]
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
Four Factor Index of Social Status
Paschou, R. (1975) · Cited by 6,989
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Four Factor Index of Social Status [1975]
Hollingshead, A. B. (1975) · Cited by 5,151
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop
Parent, A., & Hazrati, L.-N. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00007-c · Cited by 2,161
Dopamine in schizophrenia: a review and reconceptualization
Davis, K. L., Kahn, R. S., Ko, G., & Davidson, M. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,051
Physiologic Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia
Weinberger, D. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020020004 · Cited by 2,025
Negative v Positive Schizophrenia
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070025006 · Cited by 2,008
Cited by
Sorted by citations
Items 401–500 of 565
Dopamine dysfunction in schizophrenia
Abi-Dargham, A. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.09.069 · Cited by 10
Self-citationPreclinical Effects of Antipsychotic Drugs
Berrío, J. P., & Ellenbroek, B. A. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_447 · Cited by 8
Polypharmacy- Purpose, Benefits and Limitations
Grover, D., Tom, M., Maguire, G., & Stahl, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220107153813 · Cited by 7
Prior Expectations of Volatility Following Psychotherapy for Delusions
Sheffield, J. M., Sloan, A. F., Corlett, P. R., Rogers, B. P., Vandekar, S., Liu, J., Beals, K., Hall, L. M., Gautier, T., Moussa‐Tooks, A. B., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.17132 · Cited by 7
Hinkley, L. B. N., Haas, S. S., Cheung, S. W., Nagarajan, S. S., & Subramaniam, K. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.08.030 · Cited by 7
Striatal dopamine D2/3 receptors in medication-naïve schizophrenia: an [123I] IBZM SPECT study
Chen, K.-C., Yang, Y.-K., Howes, O., Lee, H. I., Yeh, T.-L., Chiu, N.-T., Chen, P.-S., David, A., & Bramon, E. (2021) · Psychological Medicine · doi:10.1017/s0033291720005413 · Cited by 7
Lang, X., Xue, M., Zang, X., Wu, F., Xiu, M., & Zhang, X. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04272-7 · Cited by 7
Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials
Rao, N. P., & Remington, G. J. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.873790 · Cited by 8
Dysfunction of Magnocellular/dorsal Processing Stream in Schizophrenia
Chieffi, S. (2019) · Current Psychiatry Research and Reviews · doi:10.2174/1573400515666190119163522 · Cited by 8
Petty, A. E., Cui, X., Ali, A. A., Du, Z., Srivastav, S., Kesby, J. P., Kirik, D., Howes, O. D., & Eyles, D. W. (2021) · Scientific Reports · doi:10.1038/s41598-021-83681-4 · Cited by 7
Rakovska, A., Javitt, D., Petkova-Kirova, P., Balla, A., Ang, R. L., & Kalfin, R. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.08.005 · Cited by 4
Presynaptic Dopaminergic Function: Implications for Understanding Treatment Response in Psychosis
Bonoldi, I., & Howes, O. D. (2014) · CNS Drugs · doi:10.1007/s40263-014-0177-z · Cited by 8
Tardive dyskinesia in schizophrenia
Liddle, P. F. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.112.123679 · Cited by 7
Kolomeets, N. S., & Uranova, N. A. (2023) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2023123011103 · Cited by 6
Supekar, K., Angeles, C. D. L., Ryali, S., Kushan, L., Schleifer, C. H., Repetto, G. M., Crossley, N. A., Simon, T., Bearden, C. E., & Menon, V. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02495-8 · Cited by 6
van Hooijdonk, C. F. M., Tse, D. H. Y., Roosenschoon, J., Ceccarini, J., Booij, J., van Amelsvoort, T., & Vingerhoets, C. (2022) · Genes · doi:10.3390/genes13091672 · Cited by 6
Liu, L., Li, Z., Kong, D., Huang, Y., Wu, D., Zhao, H., Gao, X., Zhang, X., & Yang, M. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03067-8 · Cited by 6
Self-citationCaravaggio, F., Iwata, Y., Plitman, E., Chavez, S., Borlido, C., Chung, J. K., Kim, J., Agarwal, S. M., Gerretsen, P., Remington, G. J., et al. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.12.002 · Cited by 6
Zhu, C., Guan, X., Wang, Y., Liu, J., Kosten, T. R., Xiu, M., Wu, F., & Zhang, X. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01242-7 · Cited by 6
Merrer, J. L., Detraux, B., Gandía, J., Groote, A. D., Fonteneau, M., d’Exaerde, A. D. K., & Becker, J. A. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.28.518147 · Cited by 6
Sharma, E., Mehta, D. S., Jadhav, N., Gujrati, G., Dhananya, S., Moorthy, M., Ramaswamy, G., Zhou, Y., & Nair, S. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1512727 · Cited by 5
Kolomeets, N. S., & Uranova, N. A. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01869-x · Cited by 5
Tsartsalis, S., Tournier, B. B., & Millet, P. (2020) · EJNMMI Research · doi:10.1186/s13550-020-00650-0 · Cited by 5
ÇORUM, E. N. (2024) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.1535133 · Cited by 4
Hypermethylation and increased expression of the DRD2 gene in schizophrenia
Qing, L., Zou, T., Yin, W., Wu, R., Cheng, T., Yuan, H., Zhou, C., Chen, X., Wang, J., Yang, T., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07154-y · Cited by 4
Freitas, I. D. S., Guimarães, F. S., & Gomes, F. V. (2025) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgaf029 · Cited by 4
Uliana, D., Martinez, A., & Grace, A. A. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.10.003 · Cited by 3
Kurose, S., Kubota, M., Takahata, K., Yamamoto, Y., Fujiwara, H., Kimura, Y., Ito, H., Takeuchi, H., Mimura, M., Suhara, T., et al. (2021) · Human Brain Mapping · doi:10.1002/hbm.25538 · Cited by 3
Decreased serum levels of α‐synuclein in patients with schizophrenia and their unaffected siblings
Göverti, D., Büyüklüoğlu, N., Yüksel, R. N., Kaya, H., Yücel, Ç., & Göka, E. (2023) · Early Intervention in Psychiatry · doi:10.1111/eip.13398 · Cited by 4
Schwartz, P. J. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.10.014 · Cited by 4
Imaging the Dopamine D3 Receptor In Vivo
Slifstein, M., Rabiner, E. A., & Gunn, R. N. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418677-4.00011-7 · Cited by 4
Self-citationGoal-Directed Deficits in Schizophrenia
Morris, R. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812098-9.00017-6 · Cited by 4
Modeling Psychiatric Disorders in Experimental Animals
Moore, H. M., & Robbins, T. W. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch17 · Cited by 4
Neuromelanin MRI: Dark Substance Shines a Light on Dopamine Dysfunction and Cocaine Use
Bradberry, C. W. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20091305 · Cited by 6
Age- and sex-dependent effects of stressors on activity of the nucleus reuniens of the thalamus
Uliana, D. L., & Grace, A. A. (2025) · Schizophrenia Research · doi:10.1016/j.schres.2025.09.018 · Cited by 3
Żełabowski, K., Pichowicz, W., Dembowska, J., Szwajkowski, M., Mykhailova, D., Wurm, G., Biedka, K., Błaszczyk, K., & Piotrowski, P. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1774437 · Cited by 3
Silverstein, S. M., Zolnik, T. A., Larkum, M. E., & Thompson, J. L. (2026) · Current Research in Neurobiology · doi:10.1016/j.crneur.2026.100165 · Cited by 4
Fine-scale striatal parcellation using diffusion MRI tractography and graph neural networks
Gao, J., Liu, M., Qian, M., Tang, H., Wang, J., Ma, L., Li, Y., Dai, X., Wang, Z., Lu, F., et al. (2025) · Medical Image Analysis · doi:10.1016/j.media.2025.103482 · Cited by 3
Dopamine Receptors and Dopamine Release
KESSLER, R. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418677-4.00012-9 · Cited by 3
Probabilistic association learning in schizophrenia
Weickert, T. W. (2017) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2017.08.015 · Cited by 4
Neurochemical models of psychosis risk and onset
Oliver, D., Modinos, G., & McGuire, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813201-2.00012-0 · Cited by 2
Mathematical Models of Neuromodulation and Implications for Neurology and Psychiatry
Best, J. A., Nijhout, H. F., & Reed, M. C. (2017) · Springer series in bio-/neuroinformatics · doi:10.1007/978-3-319-49959-8_8 · Cited by 3
Dopamine Receptor Imaging in Schizophrenia
Hirvonen, J., & Hietala, J. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418677-4.00013-0 · Cited by 3
Haloperidol ameliorates androgen-induced behavioral deficits in developing male rats
Qi, C., Ji, X., Zhang, G., Kang, Y., Huang, Y., Cui, R., Li, S., Cui, H., & Shi, G. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0642 · Cited by 3
Self-citationMehta, T., Murala, S., & Siddiqui, J. (2022) · Springer eBooks · doi:10.1007/978-3-031-07897-2_1 · Cited by 3
Circadian rhythms in auditory hallucinations and psychosis
Ngo, H.-V. V., Oster, H., Andreou, C., & Obleser, J. (2023) · Acta Physiologica · doi:10.1111/apha.13944 · Cited by 3
A corticostriatal learning mechanism linking excess striatal dopamine and auditory hallucinationsPreprint
Lakshminarasimhan, K. J., Buck, J., Kellendonk, C., & Horga, G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.18.643990 · Cited by 3
Neural fingerprints of data driven cognitive subtypes across the psychosis spectrum: a B-SNIP study
Meda, S. A., Dykins, M. M., Hill, S. K., Clementz, B. A., Keedy, S., McDowell, J. E., Ivleva, E. I., Gershon, E. S., Keshavan, M. S., Tamminga, C. A., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03422-3 · Cited by 2
Wang, L., Liu, R., Liao, J., Fan, L., Zhuo, L., & Li, H. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1695904 · Cited by 1
Zhang, J., Deng, X., Lv, J., Lu, J., Wang, L., Wang, W., Lei, H., Wang, Y., & Tian, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1759454 · Cited by 2
Jo, W., Moon, S., Sim, H., Park, I., Kwon, M. J., Kim, S., Jung, W. H., Kim, K. W., & Kim, E. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03967-x · Cited by 2
The impact of subcaudate tractotomy on delusions and hallucinations in psychotic patients
Vilela-Filho, O., Ragazzo, P. C., Canêdo, D., Barreto, U. S., de Oliveira, P. M., Goulart, L. C., Reis, M. D., & Campos, T. M. (2021) · Surgical Neurology International · doi:10.25259/sni_599_2021 · Cited by 2
Nestor, P. G., Levin, L. K., Stone, W. S., Giuliano, A. J., Seidman, L. J., & Levitt, J. J. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.08.027 · Cited by 2
Chafee, M. V. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_407 · Cited by 2
Connectivity alterations of mesostriatal pathways in first episode psychosis
Hayward, N., Triana, A. M., Panula, J. M., Kieseppä, T., Suvisaari, J., & Raij, T. T. (2023) · Schizophrenia · doi:10.1038/s41537-023-00339-y · Cited by 2
Gwilt, M., Hodgson, A. R., Axelsson, S. F. A., Cockcroft, G. J., McIver, L. B., Hird, M., Stasiak, A., McKenzie, C., Ip, S., Cardinal, R. N., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu0975 · Cited by 2
An ace in the hole? Opportunities and limits of using mice to understand schizophrenia neurobiology
Villarin, J. M., & Kellendonk, C. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03060-7 · Cited by 2
Forging a Role for Iron in the Dopamine Dysfunction of Schizophrenia
Cassidy, C., Wang, Y., & Abi‐Dargham, A. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20250639 · Cited by 2
Self-citationGlutamate and Schizophrenia: From Theory to Treatment Implications
Javitt, D. C. (2014) · Cited by 2
Zhang, T., Zhang, Q., Wang, C., & Chen, A. (2017) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2017.02.009 · Cited by 2
Gault, J., Thompson, J. A., Maharajh, K., Hosokawa, P. W., Stevens, K. E., D, A. O. M., Liedtke, E. I., Ojemann, A., Ojemann, S. G., & Abosch, A. (2020) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.13101 · Cited by 2
Dopamine and Response to Antipsychotic Medication
Ntephe, C., & Demjaha, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_14 · Cited by 2
Buchsbaum, M. S., Mitelman, S. A., Christian, B. T., Merrill, B., Buchsbaum, B. R., Mitelman, D., Mukherjee, J., & Lehrer, D. S. (2021) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2021.111428 · Cited by 2
The neuromediator mechanisms of the cognitive deficit in schizophrenia
Storozheva, Z. I., Kirenskaya, A. V., & Proshin, A. T. (2015) · Neurochemical Journal · doi:10.1134/s1819712415030095 · Cited by 2
Kozlovskiy, V. I., Kosterin, D. N., & Popov, M. Y. (2019) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2019-1-3-7 · Cited by 2
Personality Dimensions in Psychopathy: Potential Explanatory Models for Primary and Secondary TraitsPreprint
Murphy, B. A., & Giurgiutiu, D. (2012) · SSRN Electronic Journal · doi:10.2139/ssrn.1978268 · Cited by 1
Sherin, J. E., & Marder, S. R. (2011) · doi:10.1002/9780470978672.ch6 · Cited by 2
Neurobiology of psychosis and schizophrenia 2022: Nottingham meeting
Sami, M. B., & Liddle, P. F. (2023) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2023.152415 · Cited by 1
Boiko, A. S., Paderina, D. Z., Викторовна, М. Е., Kornetova, E. G., Bokhan, N. A., & Ivanova, S. А. (2024) · Нейрохимия · doi:10.31857/s1027813324010052 · Cited by 1
Weidenauer, A., Ramesh, R. G., Lalang, N., Watts, J. J., Lepage, M., Rusjan, P., & Mizrahi, R. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae212 · Cited by 1
Tse, P. U. (2024) · doi:10.1093/oso/9780198901181.001.0001 · Cited by 2
Ataniya, R., Koike, T., & Inamoto, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094003 · Cited by 1
Choe, E., Park, H., Jang, J., Kim, M., & Kwon, J. S. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03567-1 · Cited by 1
Lin, Z., Guan, X., Lang, X., Xiu, M., & Wu, F. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-02160-3 · Cited by 1
Cognitive Deficits in Schizophrenia: Brain Deorganization and Neurorehabilitation
Gialama, V., Dimitriou, N., Σκώκου, Μ., & Nasios, G. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-03398-7_3 · Cited by 1
Optimising therapy for schizophrenia and depression: old and new solutions
Titmarsh, S. (2012) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.259
Ellenbroek, B. A., & Youn, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801657-2.00009-4 · Cited by 1
Aripiprazole, Aripiprazole Monohydrate, and Aripiprazole Lauroxil
Meyer, J. M., & Stahl, S. M. (2021) · Cambridge University Press eBooks · doi:10.1017/9781009002103.019 · Cited by 1
The MAM Model to Study the Role of Dopamine in Schizophrenia
Zhu, X., Uliana, D. L., & Grace, A. A. (2022) · Neuromethods · doi:10.1007/978-1-0716-2799-0_10 · Cited by 1
Kolomeets, N. S., & Uranova, N. A. (2023) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-023-01509-2 · Cited by 1
Gangadhar, B. N., & Rao, N. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397025-1.00115-9 · Cited by 1
Extending Corticostriatal Systems
Deutch, A. Y. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0242 · Cited by 1
Cannabis use in delusional infestation with folie à deux
Lee, J. S., Dean, E. A., & Jimenez, X. F. (2020) · Journal of Substance Use · doi:10.1080/14659891.2020.1833094 · Cited by 1
Červenka, S., & Farde, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-35206-6_8 · Cited by 1
Spann, D. J., Straub, K. T., Hua, J. P. Y., Pellegrini, A. M., & Kerns, J. G. (2022) · Cognitive Neuropsychiatry · doi:10.1080/13546805.2022.2126302
Brown, N. K., Roche, J. K., Farmer, C. B., & Roberts, R. C. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02593-x · Cited by 1
Studying biomarkers in populations at genetic and clinical high risk for psychosis
de Koning, M. B. (2013) · doi:10.26481/dis.20131129mk · Cited by 1
Mathur, N. (2012) · Nottingham ePrints (University of Nottingham) · Cited by 1
Gallander, K. (2012) · CSUN ScholarWorks (California State University, Northridge) · Cited by 1
Dinh, T., Nerland, S., Maximov, I. I., Barth, C., Vernon, A. C., Agartz, I., & Jørgensen, K. N. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.20.496804 · Cited by 1
Kwon, J. S., Choi, S., Kim, M., Kim, T., Choi, E., Lee, J., Moon, S. Y., Cho, S. S., & Lee, J. (2023) · Research Square · doi:10.21203/rs.3.rs-2725867/v1 · Cited by 1
Li, Z., Mukherjee, D., Duric, B., Austin-Zimmerman, I., Trotta, G., Spinazzola, E., Quattrone, D., Murray, R. M., & Forti, M. D. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.15.571463 · Cited by 1
The Impact of Genetic Polymorphisms on Neuroreceptor Imaging
Willeit, M., Kasper, S. F., & Praschak-Rieder, N. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_6
Muneoka, K. T., & Kuwagat, M. (2013) · InTech eBooks · doi:10.5772/55348
Epidemiological and biological mechanisms of cannabis as cause of psychosis
Kuepper, R. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120504rk
Evaluation of novel dual-hit models of 'schizophrenia-like' symptoms in the rat
Gaskin, P. L. R. (2014) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Das soziale Gehirn und schizophrene Erkrankungen
Löffler, N., Berkefeld, A., Kaaden, S., Reiff, J., & Braus, D. F. (2011) · Nervenheilkunde · doi:10.1055/s-0038-1627796
Delfin, C. (2014) · Högskolan Kristianstad Publikationer
Stone, J. M., Howes, O. D., Egerton, A., Kambeitz, J. P., Allen, P., Lythgoe, D. J., Tuura, R., McLean, M. A., Barker, G. J., & McGuire, P. K. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.039
Behaviour and biomarkers in frontotemporal dementia: Implications for general psychiatry
Wijeratne, C. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412439054
Metadata
- Authors
- Kegeles, L. S., Abi-Dargham, A., Frankle, W. G., Gil, R., Cooper, T. B., Slifstein, M., Hwang, D.-R., Huang, Y., Haber, S. N., & Laruelle, M.
- Affiliations
- Columbia University Irving Medical Center (US)
- ORCID
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2010-03-01
- Volume
- 67
- Issue
- 3
- Pages
- 231
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W1999984108
- Cited by
- 565
- References
- 89
- Citations by year
- 2026: 17 · 2025: 26 · 2024: 33 · 2023: 25 · 2022: 42 · 2021: 23 · 2020: 32 · 2019: 42 · 2018: 32 · 2017: 38 · 2016: 45 · 2015: 41 · 2014: 47 · 2013: 32 · 2012: 47
- FWCI
- 25.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (K02MH01603-01, K02MH001603, R01MH054192)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- schizophrenia, synaptic dopamine, associative striatum, dorsal caudate, dopamine depletion, mesolimbic dopamine system, dopamine hypothesis of schizophrenia, atypical antipsychotics, dorsolateral prefrontal cortex, positron emission tomography, raclopride
- MeSH terms
- Adult, Brain Mapping, Carbon Radioisotopes, Caudate Nucleus, Corpus Striatum, Dopamine, Female, Humans, Image Processing, Computer-Assisted, Male, Synaptic Transmission, Putamen, Schizophrenia, Synapses, Case-Control Studies, Prefrontal Cortex, Receptors, Dopamine D2, alpha-Methyltyrosine, Raclopride, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review